CDC-RFA-IP-25-0007 strengthening vaccine preventable disease prevention and response - strengthening vaccine-preventable disease prevention and response maine project abstract maine's unique…

Active Cooperative Agreement Awarded Last action

Award ID
NH23IP922721
Recipient
Awarding agency
Obligated
$4,093,081

Award facts

Completion date 27% complete
Funding agency
National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Maine, USA

Award details come from USAspending.gov.

Description

CDC-RFA-IP-25-0007 strengthening vaccine preventable disease prevention and response - strengthening vaccine-preventable disease prevention and response maine project abstract maine's unique demographic and geographic characteristics present distinct challenges in public health service delivery, particularly in vaccine accessibility and immunization efforts. The maine immunization program (MIP), housed within the maine centers for disease control (maine CDC), is dedicated to strengthening vaccine-preventable disease prevention and response through enhanced outreach, education, and access initiatives. Despite progress in childhood immunization rates-exceeding the 95% herd immunity threshold as of the 2023-2024 school year-barriers such as misinformation, vaccine hesitancy, and logistical constraints persist. MIP's strategic objectives focus on expanding vaccine access, improving immunization rates, reducing misinformation, and supporting communities with lower vaccination rates. Key strategies include bolstering program infrastructure, expanding community outreach, implementing targeted public education campaigns, and fostering strong collaborations with healthcare providers and stakeholders. A significant component of MIP's future efforts involves developing a universal adult immunization program, ensuring equitable vaccine access for individuals over 19 while reducing healthcare costs. To measure impact, MIP will implement a comprehensive evaluation plan incorporating both qualitative and quantitative data, leveraging the immunization information system (IIS) and epidemiological analysis to refine strategies and enhance program effectiveness. Through sustained funding, MIP aims to safeguard public health by ensuring vaccine accessibility, countering misinformation, and maintaining high immunization rates across maine. Strengthening partnerships with state, regional, and national organizations will further enhance the state's capacity to prevent vaccine-preventable diseases and protect its residents for years to come.

Transactions

Action Obligated Date
Amendment $428,126
Amendment $0
Amendment $0
Amendment $113,675
Amendment $113,675
Amendment $113,675
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $1,070,187
Amendment $113,369
Amendment $1,070,187
Original award $113,369
Show all 17

Quick answers

Who received award NH23IP922721?

NH23IP922721 was awarded to Maine Department Of Health And Human Services by Office of Financial Resources (Centers for Disease Control and Prevention) on July 1, 2025.

How much is award NH23IP922721 worth?

$4,093,081 has been obligated on NH23IP922721.

Which agency awarded NH23IP922721?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded NH23IP922721, with funding from National Center for Immunization and Respiratory Diseases (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award